The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1358
In Brief: Human Chorionic Gonadotropin (hCG) for Weight Loss
Download PDF:   US English
Med Lett Drugs Ther. 2011 Feb 21;53(1358):16
Disclosures
Objective(s)
 Select a term to see related articles  hCG   Novarel   Pregnyl   weight loss 

A Medical Letter reader asked if human chorionic gonadotropin (hCG; Novarel, Pregnyl and others) has any value as an adjunct to diet, adding that it is widely used for this indication in his area. Normally secreted by the placenta during pregnancy, the main therapeutic use of this gonad-stimulating polypeptide, which is not absorbed from the GI tract, has been in the parenteral treatment of infertility.1 It has also been injected by male athletes as an undetectable stimulus to production of testosterone.2

Use of hCG as an adjunct to diet goes back to the 1950’s, when a British physician named Simeons recommended daily injections of the hormone combined with a 500 kcal diet, and such use came to be known as the Simeons method. One double-blind study after another throughout the second half of the 20th century found hCG to be worthless for weight loss or maintenance.3

© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
arrow to previous article
arrow to next article